Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
9.03
-0.01 (-0.11%)
At close: Dec 20, 2024, 4:00 PM
8.99
-0.04 (-0.44%)
After-hours: Dec 20, 2024, 4:06 PM EST
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AUPH stock have an average target of 10.33, with a low estimate of 8.00 and a high estimate of 13. The average target predicts an increase of 14.40% from the current stock price of 9.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 16, 2024.
Analyst Ratings
The average analyst rating for AUPH stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | +10.74% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | +10.74% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +43.96% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +43.96% | Mar 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +10.74% | Feb 23, 2024 |
Financial Forecast
Revenue This Year
240.40M
from 175.51M
Increased by 36.97%
Revenue Next Year
279.89M
from 240.40M
Increased by 16.43%
EPS This Year
0.03
from -0.54
EPS Next Year
0.58
from 0.03
Increased by 2,100.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 251.1M | 311.1M | 414.5M | |||
| Avg | 240.4M | 279.9M | 344.4M | |||
| Low | 228.4M | 245.0M | 288.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 43.0% | 29.4% | 48.1% | |||
| Avg | 37.0% | 16.4% | 23.1% | |||
| Low | 30.1% | 1.9% | 2.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.23 | 0.72 | 1.17 | |||
| Avg | 0.03 | 0.58 | 0.81 | |||
| Low | -0.05 | 0.44 | 0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 2,631.9% | 99.8% | |||
| Avg | - | 2,100.0% | 38.8% | |||
| Low | - | 1,562.9% | -19.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.